Federation of Pharma Entrepreneurs

What Federation of Pharma Entrepreneurs does

Federation of Pharma Entrepreneurs (FOPE) is a nonprofit industry association founded in 2006 and headquartered in Gurugram, Haryana, India, representing pharmaceutical entrepreneurs and businesses in collective engagement with the Government of India. The federation serves as an intermediary between its members and key regulatory bodies including the Central Drugs Standard Control Organization (CDSCO), the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Health & Family Welfare (MoHFW), the Directorate General of Foreign Trade (DGFT), the Indian Pharmacopoeia Commission (IPC), and NITI Aayog. It conducts policy advocacy on issues such as drug pricing, excise duty on finished formulations, fixed dose combinations, and amendments to the spurious drugs act, and disseminates regulatory circulars, gazette notifications, and government updates to its member base.

FOPE's core offerings are membership-based services rather than discrete products. Revenue is generated primarily through annual membership fees, supplemented by publication sales and advertising, event and webinar registration fees, donations, and fees from UCPMP (Uniform Code for Pharmaceutical Marketing Practices) complaint registration. The association operates state chapters across India, holds an annual general meeting (the 18th was held in 2025), and runs a PULSE Series covering topics such as Revised Schedule M and GST on pharmaceuticals. Distribution is via direct membership enrollment through its website, supported by digital channels including LinkedIn, Facebook, Twitter/X, Instagram, YouTube (@FopeForHope), and email newsletters.

The association is governed by elected office bearers including Patron-in-Chief R.C. Juneja (Chairman of Mankind Pharma), Chairman B R Sikri (Next Wave India), and National President Harish K Jain (Embiotic Laboratories). It received the Best Association Award at the Pharma Ratna 2025 function. FOPE maintains cross-association partnerships with CIPI, CII, and FABA, and has been invited to participate in international forums such as PHARMAP 2025 in Berlin. The organization does not operate any technology products, software platforms, or AI-driven services; its value proposition is grounded entirely in regulatory access, policy advocacy, and community aggregation for Indian pharmaceutical entrepreneurs.

Name

Federation of Pharma Entrepreneurs

Legal name

Federation of Pharma Entrepreneurs (FOPE)

Website

https://fopeindia.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Federation of Pharma Entrepreneurs (FOPE) is a nonprofit industry association, founded in 2006 and based in Gurugram, India, that represents pharmaceutical entrepreneurs through collective advocacy with Indian regulatory bodies including CDSCO, NPPA, and MoHFW. It funds operations via annual membership fees, events, publications, donations, and UCPMP complaint registration.

Ownership category

akta.pro rank

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: FOPE generates revenue primarily through annual membership fees from pharmaceutical entrepreneurs and companies. The membership is available for renewal and new enrollment, with fees serving as the core recurring revenue stream for the association.
2. Publications: Revenue is generated from sale of FOPE publications and advertisements placed in association publications.
3. Event Registration: Fees collected for participation in seminars, conferences, webinars, and other FOPE-organized events.
4. Donations: Donations received towards FOPE activities from members and supporters.
5. UCPMP Complaint Registration: Fees collected for UCPMP (Uniform Code for Pharmaceuticals Marketing Practices) complaint registration.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Federation of Pharma Entrepreneurs (FOPE) is a national industry association founded in 2006 that represents pharmaceutical entrepreneurs in India to government ministries and regulatory departments. It provides annual membership services, disseminates regulatory circulars and government notifications from bodies such as CDSCO, NPPA, DGFT, and IPC, organizes industry events and webinars, publishes newsletters, operates a UCPMP complaints portal, and conducts policy advocacy on drug pricing, fixed dose combinations, excise duty, and spurious drugs act amendments.

Product overview

The Federation of Pharma Entrepreneurs (FOPE) is an industry association for pharmaceutical entrepreneurs in India, formed in 2006. Rather than a product company, FOPE provides membership services, regulatory compliance resources, and industry representation. The organization offers circulars and government notifications related to pharmaceutical regulations (CDSCO, NPPA, DPCO), publishes newsletters (FOPE Newsletter), facilitates events such as webinars and seminars (including sessions on Revised Schedule M, GST reduction on pharma), maintains a UCPMP (Uniform Code of Pharmaceutical Marketing Practices) complaints portal, presents industry awards (Best Association Award at Pharma Ratna 2025), and advocates with government bodies such as NITI Aayog. Membership renewal periods run annually (e.g., 2025-26, 2026-27). The association operates state chapters and facilitates policy recommendations for pharma and biotech MSMEs.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual FOPE Membership Annual subscription-based membership for pharmaceutical entrepreneurs and companies in India, providing access to regulatory updates, advocacy representation, events, and networking with government bodies.
• UCPMP Complaints Portal Fee-based complaint registration service under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), allowing members and industry stakeholders to file and process marketing practice complaints.
• FOPE Events and Webinars Paid seminars, conferences, webinars, and interactive sessions organized by FOPE, including joint sessions with regulators such as CDSCO on topics like Revised Schedule M and pharma GST reduction.
• FOPE Publications and Newsletter Sale of FOPE publications, including the FOPE Newsletter and PULSE Series on Revised Schedule M, along with advertisements placed in association publications.

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered moderate, core and minor.

• CIPI (Confederation of Indian Pharmaceutical Industry)moderateStrategic or Co-development Partner · 26 August 2025FOPE and CIPI jointly organized an interactive session with CDSCO held at The Ashok, New Delhi to discuss regulatory matters affecting the pharmaceutical industry.
• CDSCO (Central Drugs Standard Control Organization)coreOthersFOPE maintains an active engagement with CDSCO, conducting interactive sessions and receiving regulatory updates. The association serves as a key stakeholder in advising on pharmaceutical regulatory matters.
• NPPA (National Pharmaceutical Pricing Authority)coreOthersFOPE advocates on drug pricing matters with NPPA, representing the interests of pharmaceutical entrepreneurs on pricing policies and ceiling price regulations.
• MoHFW (Ministry of Health & Family Welfare)coreOthersFOPE engages with the Ministry of Health & Family Welfare on policy matters affecting the pharmaceutical industry, including drugs and cosmetics regulations.
• DGFT (Directorate General of Foreign Trade)moderateOthersFOPE monitors and communicates foreign trade policy updates relevant to pharmaceutical exports and imports to its members.
• IPC (Indian Pharmacopoeia Commission)moderateOthersFOPE disseminates Indian Pharmacopoeia updates and draft revisions to members for compliance purposes.
• NITI AayogmoderateOthersFOPE submitted policy recommendations to NITI Aayog for strengthening Pharma & Biotech MSMEs during a FABA Roundtable discussion.
• CII (Confederation of Indian Industry)minorOthersMr. Chakravarthi AVPS was appointed as Convener of CII Telangana Pharma & Lifesciences Committee, indicating cross-association collaboration.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Organisation of Pharmaceutical Producers of India (OPPI): Industry body representing multinational and research-based pharmaceutical companies in India. Comparable as a pharma trade association engaging with government on policy, though OPPI's membership is skewed toward foreign MNCs versus FOPE's entrepreneur/MSME base.
• Indian Pharmaceutical Alliance (IPA): Alliance of large Indian pharma companies that, like FOPE, represents pharma manufacturers in policy advocacy with the Indian government. Most directly comparable as an industry association serving Indian pharma, though IPA's membership skews toward larger research-based companies whereas FOPE focuses on entrepreneurs/MSMEs.
• Indian Drug Manufacturers' Association (IDMA): One of the oldest Indian pharma industry associations representing manufacturers across formulations and bulk drugs. Directly comparable to FOPE in mission (advocacy, regulatory engagement, member services), with overlapping but distinct membership constituencies.
• Pharmaceuticals Export Promotion Council of India (Pharmexcil): Export promotion council for pharma, set up by the Indian government. Comparable as an industry body serving Indian pharma companies with regulatory facilitation, trade policy advocacy, and member support services.
• Bulk Drug Manufacturers Association of India (BDMAI): Association representing bulk drug (API) manufacturers in India. Comparable trade association focused on a specific sub-segment of pharma manufacturing, with similar advocacy, regulatory updates, and member services.
• Confederation of Indian Pharmaceutical Industry (CIPI): Indian pharma industry confederation that has directly co-organized events with FOPE (joint CDSCO session). Most directly comparable as a peer association serving pharma companies with policy advocacy and regulatory engagement.

Broad incumbents

• Confederation of Indian Industry (CII): Large industry chamber with a pharma vertical. Not a dedicated pharma association but a broader incumbent that overlaps with FOPE on industry advocacy and where FOPE leaders serve on pharma committees.
• Federation of Indian Chambers of Commerce and Industry (FICCI): Major Indian industry chamber with a pharma committee. Comparable in its role as a broad industry advocacy body engaging government on pharma policy, though not specialized to pharma entrepreneurs/MSMEs.
• Associated Chambers of Commerce and Industry of India (ASSOCHAM): Pan-India industry chamber with dedicated pharma and life sciences councils. Comparable as a multi-industry body where pharma entrepreneurs can access advocacy, networking, and policy engagement services that partially substitute for FOPE's offering.

Emerging players

• Indian Pharmaceutical Association (IPA - scientific body): Professional association of pharmacists rather than pharma entrepreneurs/companies. Adjacent to FOPE in the pharma ecosystem with overlapping regulatory engagement, though its focus is more scientific/professional than commercial advocacy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@FopeForHope
• Facebookfacebook.com/login
• LinkedInlinkedin.com/company/federation-of-pharma-entrepreneurs

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Federation of Pharma Entrepreneurs